Shenzhen Bioeasy Biotechnology Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Zhaoli Xiao
Chief executive officer
CN¥1.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.8yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 1.1yrs |
Recent management updates
Recent updates
Is Shenzhen Bioeasy Biotechnology (SZSE:300942) A Risky Investment?
Mar 19
Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) 26% Price Boost Is Out Of Tune With Revenues
Nov 27Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) 28% Price Boost Is Out Of Tune With Revenues
Sep 30Subdued Growth No Barrier To Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) Price
Jun 26Shenzhen Bioeasy Biotechnology Co., Ltd. (SZSE:300942) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Mar 08CEO
Zhaoli Xiao (50 yo)
2.8yrs
Tenure
CN¥1,174,400
Compensation
Mr. Zhaoli Xiao is Chairman & GM of Shenzhen Bioeasy Biotechnology Co. Ltd. from September 27, 2023. He was Deputy GM & Non-Independent Director of Shenzhen Bioeasy Biotechnology Co. Ltd.from July 2022.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 2.8yrs | CN¥1.17m | no data | |
| Deputy GM & Non-Independent Director | 1.1yrs | CN¥968.70k | no data | |
| Deputy GM | 1.6yrs | CN¥338.40k | no data | |
| Non-Independent Director | 1.1yrs | CN¥288.70k | no data | |
| Independent Director | 1.1yrs | no data | no data | |
| Supervisor | 1.1yrs | no data | no data | |
| Independent Director | 1.6yrs | CN¥19.40k | no data | |
| Independent Director | 1.6yrs | CN¥19.40k | no data | |
| Chairman of Supervisory Board | 1.1yrs | no data | no data |
1.1yrs
Average Tenure
45yo
Average Age
Experienced Board: 300942's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/09 19:00 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shenzhen Bioeasy Biotechnology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.